Diabetes and Heart Failure in the Crosshairs: Where Is the Target?

European Journal of Heart Failure - United States
doi 10.1002/ejhf.703
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diabetes Mellitus and Heart Failure

American Journal of Medicine
Medicine
2017English

Renin Inhibition in Heart Failure and Diabetes: The Real Story

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Refractory Congestive Heart Failure: When the Solution Is Outside the Heart

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Endothelium as a Therapeutic Target in Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Metabolic Syndrome and Related Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

The Elabela-Apj Axis: A Promising Therapeutic Target for Heart Failure

Heart Failure Reviews
Cardiovascular MedicineCardiology
2020English

Heart Rate in Heart Failure With Preserved Ejection Fraction: Target or Marker?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Diabetes Mellitus and Heart Failure: A Deadly Duo

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy